Latest BioCurex Inc. Stories
RICHMOND, BRITISH COLUMBIA--(Marketwire - Oct. 3, 2008) - BioCurex Inc. (OTCBB:BOCX) today announced results showing that its RECAF test can detect cancer with high sensitivity and specificity using a small sample of saliva.
RICHMOND, BRITISH COLUMBIA--(Marketwire - Sept. 17, 2008) - BioCurex Inc. (OTCBB:BOCX) today announced that the Australian Patent Office has issued a notice of acceptance for a divisional application of our original patent filing.
BioCurex Inc. (OTCBB: BOCX) today announced that the Congress Scientific Committee has accepted its presentation to the ISOBM annual meeting.
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 24, 2008) - BioCurex (OTCBB:BOCX) is pleased to announce it has retained the services of AGORACOM Investor Relations ("AGORACOM") (http:// www.agoracom.com) to provide online investor relations services, a Web 2.0 social network for current shareholders and Tier-1 awareness through the world's biggest websites for the purpose of attracting new shareholders.
RICHMOND, British Columbia, July 3, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) is aware of the recent trading activity in the company's stock and notes that there has been no material change in the business of the Company to support this activity.
RICHMOND, British Columbia, Nov. 30, 2004 (PRIMEZONE) -- BioCurex Inc. (Pink Sheets:BOCX) BioCurex Inc. is pleased to report its findings on RECAF(tm) serum testing of Prostate cancer specimens.
- totally perplexed and mixed up.